This inventor holds 2 USPTO granted patents. Top assignee: Cell Therapeutics, Inc.. Active years: 1996-1999.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1996-1999
Title: Elisa Eiseman: Innovator in Allergy Treatment
Introduction
Elisa Eiseman is a prominent inventor based in Seattle, WA, known for her contributions to the field of allergy treatment. With a focus on innovative methods to inhibit mast cell and basophil activation, she has made significant strides in addressing allergic disorders. Her work has led to the development of two notable patents.
Latest Patents
Elisa's latest patents include a method for inhibiting mast cell and basophil activation. This method involves administering an effective amount of a compound that inhibits the intracellular generation of phosphatidic acid and diacylglycerol, which are crucial in the activation process related to allergies. Additionally, she has developed olefin-substituted long-chain compounds, which are detailed in her patent disclosures.
Career Highlights
Elisa Eiseman has made a mark in the scientific community through her innovative research and development efforts. Her work at Cell Therapeutics, Inc. has positioned her as a key player in the advancement of allergy treatments.
Collaborations
Elisa has collaborated with notable colleagues, including Gail E. Underiner and David J. Porubek, contributing to a dynamic research environment that fosters innovation.
Conclusion
Elisa Eiseman's contributions to allergy treatment through her patents and collaborative efforts highlight her role as a leading inventor in her field. Her work continues to pave the way for advancements in medical treatments for allergic disorders.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile